Terms of the contract were not disclosed.
The company said services are scheduled to start this month.
Applied DNA shares were down 2.3% in recent trading.
Price: 2.00, Change: -0.06, Percent Change: -3.15
|Insider Sell: Block|
|Insider Sell: Berkshire Hathaway|
|Insider Sell: Trupanion|
|Insider Buy: Ikena Oncology|
|Insider Sell: Apellis Pharmaceuticals|